Yes, it is entirely normal
GLP-1 agonists, through weight loss dependent mechanisms, reduce estrogen and inflammation
Besides contributing to PCOS-associated hyperandrogenism, insulin resistance is also linked the development of impaired glucose tolerance and type 2 diabetes mellitus [48], in both obese and non-obese women with PCOS [49]
Patients should bring their full medical history and medication list to any consultation so the risk discussion is specific, not generic
Does Ipamorelin have any anti-inflammatory effects
In this study people treated with CagriSema achieved a superior weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, 16.1% with semaglutide 2.4 mg and 2.3% with placebo alone